Mr. Chin-Yen Kao founded the President Enterprises Group in 1968. It is one of the largest and perhaps the most respected company in Taiwan. Mr. Kao has been its only chairman and in recent years, has formed very successful international joint ventures with the U.S.' 7-11 Convenient Stores, Pepsi Drinks, Starbucks Coffee, France's Carrefour and Germany's Allianz. Prior to establishing the President's Group, Mr. Kao was the director of sales of Tainan Spinning Company. Due to the long history of successful ventures in Taiwan as well as Mainland China, Mr. Kao is considered a legendary businessman in the Pacific Rim and has held the position of Chairman of Taiwan's Industrial Manufacturer's Association in 1999.

back to top

BS ChE; MS & Ph.D. Chemistry.

Jo Shen is the President and CEO of ScinoPharm where she also was a founding partner. She has over 25 years of experience in the management of chemical & pharmaceutical businesses with in-depth experiences in strategic planning, business and organization development, technology transfer, supply chain management, quality control and assurance, environmental safety & health, cGMP compliance and formulation development and manufacturing.

Before co-founding ScinoPharm, Dr. Shen was with Syntex for 14 years and Monsanto for 7 years. At Syntex, she was Corporate VP for Pharmaceutical Technology & Operations. Prior to that, she was at Monsanto as Electronic Materials Plant Manager and Superintendent of Quality Control Engineering.

Dr. Shen holds a Ph.D. in Physical Chemistry from Lehigh University, a M.S. in Inorganic Chemistry from the University of Iowa and a B.S. in Chemical Engineering from National Taiwan University. Dr. Shen has served as Chairperson of Pharmaceutical Production Committee of PhRMA and in 1991, was given a "Woman In Industry" award by the YWCA in Santa Clara.

back to top

B.S. Chemistry, Ph. D Biochemistry.

Currently the Executive Vice President of ScinoPharm Taiwan, Ltd., Dr. Chan is responsible for the company's Research and Development as well as Business Development. Dr. Chan is a co-founder of ScinoPharm and is also the Chairman of ScinoPharm Investments Ltd., a BVI registered company.

Prior to co-founding ScinoPharm, Dr. Chan was Vice President of Research and Director of Biotechnology for Syntex. Dr. Chan was also a member of Syntex's Committee on Biotechnology Investments and was a recipient of the distinguished Syntex's Chairman's Science Award.

Dr. Chan also serves as a senior adviser to the Taiwanese government, Industrial Technology Research Institute and to the Development Center for Biotechnology in Taiwan. He is currently an Adjunct Professor at the National Cheng Kung University. Dr. Chan holds a Ph.D. in Biochemistry and a B.S. in Chemistry from University of Wisconsin, Madison. Dr. Chan has over 60 scientific manuscripts in peer-reviewed journals and three published patents. .

back to top

Dr. Shih holds a Ph.D. in chemistry from Cornell University, a M.S. and B.S. both in Chemistry from Tamkang University. Dr. Shih is a member of Chinese Chemical Society, American Chemical Society, International Society Pharmaceutical Engineer.

back to top

B.S., M.S. and Ph.D., Chemistry.

Dr. Chen has 13 years experience in chemical and pharmaceutical R&D. His expertise includes medicinal chemistry, process R&D and technology transfers. At ScinoPharm, Dr. Chen is responsible for Medicinal chemistry technical service as well as peptide and oligonucleotide technology development. In addition, Dr. Chen is responsible for ScinoPharm's Kun-Shan Process R&D operation.

Prior to joining ScinoPharm in 1998, Dr. Chen was employed for 7 years in the Refining and Manufacturing Research Center of Chinese Petroleum Corporation (CPC) where he worked on specialty chemical products and in process R&D. Before CPC, he was an adjunct professor of Chemistry at Tunghai University in Taiwan for 5 years, and at Wayne State University as a postdoctoral fellow of Medicinal Chemistry for two years.

Dr. Chen holds a Ph.D. in Chemistry from Wayne State University, a M.S. in Chemistry from National Taiwan University, and a B.S. from Tunghai University. Dr. Chen is the holder of six patents.

back to top

Prior to ScinoPharm, Dr. Yang spent 8 years with Alpha-Beta Technology and 11 years with Pitman-Moore all in areas of developing biopharmaceutical products and processes, plant design and cGMP manufacturing. Earlier Dr. Yang worked for Bayer AG for 3 years and Lawrence Berkeley National Laboratory for 3 years on fermentation and enzymatic process development.

Dr. Yang holds a Ph.D. in Biochemical Engineering from the University of Pennsylvania and B.S. in Chemical Engineering from National Taiwan University. Dr. Yang has published 9 papers in scientific journals and holds 3 patents covering methods for recovering recombinant proteins.

back to top

Prior to joining ScinoPharm, Dr. Cheng worked initially as EHS Engineer, later on was promoted to the Manager of EHS, for Grand Pacific Petrochemical Corporation located in Kaohsiung Ta-She Industrial Park from 1995 to 1998.

Dr. Cheng has a B.S. degree of Chemical Engineering from National Tsing-Hua University, M.S. degree of Environmental Sciences and Engineering from University of North Carolina at Chapel Hill, and Ph.D. of Industrial Hygiene from Johns Hopkins University. He is an active member of American Industrial Hygiene Association (AIHA) and was registered as qualified Environmental Auditor with Environmental Auditors Registration Association (EARA) in UK. He is also a certified class-A air pollution control professional and certified class-A safety and health superintendent in Taiwan.

back to top